Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2

[Image: see text] Despite the availability of vaccines, COVID-19 continues to be aggressive, especially in immunocompromised individuals. Therefore, the development of a specific therapeutic agent with antiviral activity against SARS-CoV-2 is necessary. The infection pathway starts when the receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Quagliata, Michael, Stincarelli, Maria Alfreda, Papini, Anna Maria, Giannecchini, Simone, Rovero, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275481/
https://www.ncbi.nlm.nih.gov/pubmed/37387789
http://dx.doi.org/10.1021/acsomega.3c01436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275481/
https://www.ncbi.nlm.nih.gov/pubmed/37387789
http://dx.doi.org/10.1021/acsomega.3c01436

Ejemplares similares